books on digital currency- Top Knowledge

Sony has registered the trademark of space robot. According to media reports, on December 13th, TGA award ceremony was held, and AstroBot won the annual game award. This game was developed by Team ASOBI and released by Sony Interactive Entertainment. According to Tianyancha's intellectual property information, in May 2020, Sony Interactive Entertainment Co., Ltd. applied for registration of two "cosmic robots" trademarks. At present, the educational and entertainment trademarks have been successfully registered, and the scientific instrument trademarks are displayed as "revocation/invalidation application under review". However, according to the trademark documents, a company's application for invalidation of such trademarks has been rejected. In addition, in November 2019, Sony applied to register two trademarks of "Cosmic Robot Search and Rescue Action", which are internationally classified as educational entertainment and scientific instruments. At present, they have all been rejected and are in an invalid state.Spot gold fell below $2,680 per ounce, down 1.38% in the day. COMEX gold futures fell 2.00% in the day and are now reported at $2701.50 per ounce. 

Blinken asked Turkey to urge Hamas to agree to the hostage agreement, and US Secretary of State Blinken asked Turkey to use its relations with Hamas to urge Hamas to agree to the hostage agreement. Blinken said that during his talks with the Turkish President and Turkish Foreign Minister, he discussed the necessity of Hamas saying "yes" to the ceasefire agreement in Gaza. Blinken said: "We talked about the need for Hamas to agree to the (Gaza) agreement, which may eventually help end the war."Huifa Food: Shareholder Zhenghechang Investment Co., Ltd.' s shareholding reduction plan has not been completed yet, and Huifa Food announced the change. On November 8, 2024, the company disclosed the Announcement of Huifa Food Shareholder's shareholding reduction plan, and Shareholder Zhenghechang Investment Co., Ltd. plans to reduce its shareholding by centralized bidding to no more than 2,446,423 shares, which does not exceed 1% of the company's total share capital; The reduction of holdings through block trading does not exceed 4,892,846 shares, and does not exceed 2% of the company's total share capital. The planned reduction period is from November 29, 2024 to February 27, 2025. As of December 13, 2024, shareholder Zhenghechang Investment Co., Ltd. has reduced its shareholding by 1.7 million shares through centralized bidding. At present, the shareholder's shareholding reduction plan has not been completed.HKEx: HSBC repurchased 527,200 shares for HK$ 39.4 million on December 12.

Guangdian Express won the bid for ICBC's all-in-one local and foreign currency banknote allocation and processing project. Recently, Guangdian Express successfully won the bid for ICBC's all-in-one local and foreign currency banknote allocation and processing project, achieving a major breakthrough at the head office level for the first time in the field of smart treasury. The intelligent solution for the number of local and foreign currency banknotes won this bid strongly supports the business process optimization of ICBC's large local currency and foreign currency, helps to create a new benchmark for smart vaults in the industry, and pushes the intelligent operation of domestic vaults to a new level.Twenty-five pilot banks in Shenzhen have opened a total of 64,000 cross-border wealth management accounts. The reporter was informed that by the end of November 2024, 25 pilot banks in Shenzhen had opened a total of 64,000 cross-border wealth management accounts, with a total amount of cross-border receipts and payments of 42.74 billion yuan, accounting for 48.1% and 44.2% of Guangdong-Hong Kong-Macao Greater Bay Area respectively.Yiling Pharmaceutical Co., Ltd.: The application for clinical trial of Lianhua Yuping Granule was approved, and Yiling Pharmaceutical announced that Beijing Yiling, a wholly-owned subsidiary, received the Notice of Approval for Clinical Trial of Drugs approved and issued by National Medical Products Administration on December 12, 2024, and agreed to carry out clinical trial of Lianhua Yuping Granule for qi deficiency syndrome of common cold.